Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension-Reference-Cited by-同舟云学术

Suppression of angiotensin II-activated NOX4/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension

Published:2022-07 Issue: Volume:927 Page:175048
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Banks Trenton E.,Rajapaksha Maheshinie,Zhang Li-Hui,Bai Feng,Wang Ning-Ping,Zhao Zhi-Qing^ORCID

Publisher

Elsevier BV

Subject

Pharmacology

Reference51 articles.

1. Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes;Ago;Circ. Res.,2010

2. Angiotensin II AT1 receptor alters ACE2 activity, eNOS expression and CD44-hyaluronan interaction in rats with hypertension and myocardial fibrosis;Bai;Life Sci.,2016

3. SIRT3 regulation of mitochondrial oxidative stress;Bause;Exp. Gerontol.,2013

4. SIRT-3 modulation by resveratrol improves mitochondrial oxidative phosphorylation in diabetic heart through deacetylation of TFAM;Bagul;Cells,2018

5. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology;Bedard;Physiol. Rev.,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NADPH Oxidases in Neurodegenerative Disorders: Mechanisms and Therapeutic Opportunities;Antioxidants & Redox Signaling;2024-07-10

2. Unraveling the Cardiac Matrix: From Diabetes to Heart Failure, Exploring Pathways and Potential Medications;Biomedicines;2024-06-13

3. Linagliptin ameliorates tacrolimus-induced renal injury: role of Nrf2/HO-1 and HIF-1α/CTGF/PAI-1;Molecular Biology Reports;2024-05-05

4. The value of low-intensity pulsed ultrasound in reducing ovarian injury caused by chemotherapy in mice;Reproductive Biology and Endocrinology;2024-04-26

5. Effect of GLP-1 Receptor Agonist on Ischemia Reperfusion Injury in Rats with Metabolic Syndrome;Pharmaceuticals;2024-04-19